The Drug Information Center empowers users, by offering detailed information on prescription and non-prescription medications, supplements and vitamins, as well as a Drug Interaction Checker and a printable, personalized health information wallet cards feature. ‘Our new Drug Info Center provides a comprehensive set of assets that informs and empowers our clients as they make essential decisions encircling their health insurance and well-being,’ stated Brian Tilzer, Senior Vice President, Chief Digital Officer for CVS/pharmacy. ‘As a pharmacy invention company, we are constantly exploring new equipment and resources to help our customers on the way to better health. With this start, we are offering users medication knowledge in a simple, interactive way that delivers individualized and relevant drug information that has never been distributed around them before.’ Resources now available as part of the Drug Information Middle include: Enhanced Drug Info: Allows users to quickly seek out easy-to-understand information on a large number of drugs to help them make smarter health decisions and also have more informed consultations with their caregivers, pharmacists or physicians.At the same time, around 2.5 million children in India die from infections such as pneumonia, diarrhea, and malaria every year. In South Africa, infectious diseases account for 28 % of years of lives lost while chronic diseases account for 25 %.’ The authors add that medical providers in these countries are being strained by the dual burden. Related StoriesMD Anderson research reveals why chemotherapy medicines not effective for many pancreatic cancer patientsCrucial change in single DNA base predisposes children to intense form of cancerOvarian cancer individuals with a brief history of oral contraceptive make use of have better outcomes’Generally in most developing countries inadequate financing and insufficient manpower to address chronic diseases have been main impediments to chronic disease control.’ The authors continue, ‘Many key decision manufacturers still believe chronic illnesses afflict only the affluent and older people and arise only from freely acquired dangers and that their control is definitely ineffective and very costly and should wait until infectious illnesses are tackled.’ The authors explain that ‘chronic diseases in developing countries are not just diseases of the elderly, since coronary disease accounts for as much deaths in middle-aged and young adults as HIV/AIDS.